IVF (INVO Fertility) Cash Payments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IVF INVO Fertility Inc IVF
35 GF Score
Price $1.05
GF Value $127.85
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is INVO Fertility Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.

IVF
35GF Score
INVO Fertility Inc IVF
Cash Payments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is INVO Fertility (IVF) Overvalued in 2026?

Based on GuruFocus' analysis, INVO Fertility stock appears to be undervalued. The current stock price of $1.05 is trading 99.2% below its estimated GF Value™ of $127.85. GuruFocus considers INVO Fertility to be Possible Value Trap.

Key valuation signals for IVF:

  • Cash Payments:
  • GF Value™: $127.85 vs. price of $1.05 (99.2% below fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the IVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

INVO Fertility Business Description

Address 5582 Broadcast Court, Sarasota, FL, USA, 34240
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
35GF Score

Get the complete analysis for IVF

Cash Payments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.05
Price
$127.85
GF Value